Northumbria University
Newcastle upon Tyne, Tyne and Wear, NE1 8ST, United Kingdom
NCT Number: NCT03592251
The purpose of this study is to investigate the effects of EPA- and DHA-enriched omega-3 polyunsaturated fatty acid dietary supplements on overnight verbal and visual memory consolidation as well as morning alertness before and after 26 weeks of supplementation
Looking for future studies?
Notify Me25 year–49 year
All sexes
Interventional
Not applicable
Newcastle upon Tyne, Tyne and Wear, NE1 8ST, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
6 months placebo supplementation
6 months placebo supplementation
6 months placebo supplementation
Time frame: 26 months
Delayed recall accuracy
Time frame: 26 months
Delayed recall accuracy
Time frame: 26 months
Learning index
Time frame: 26 months
Learning index
Time frame: pre, Mid and post dose measures
Planning time (ms)
Time frame: pre, Mid and post dose measures
Completion time (ms)
Time frame: pre, Mid and post dose measures
Errors (number)
Time frame: 26 months
reaction time speed from a simple reaction task
Time frame: 26 months
accuracy (%)
Time frame: 26 months
Reaction time (ms)
Time frame: 26 months
Subjective ratings of alertness upon waking on a visual analogue scale (0-100 with 100 denoting the most alert the participant has ever felt in their life)
Northumbria University
Other
Efficacy Evaluation of 26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Memory Consolidation in Healthy Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05746299
Memory Consolidation
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07721272
Brain Diseases, Central Nervous System Diseases
Dallas, Texas, United States
View Trial DetailsNCT06967935
Brain Diseases, Central Nervous System Diseases
Bron, France
View Trial DetailsNCT06954922
Brain Diseases, Central Nervous System Diseases
View Trial Details